Please login or register to print this page.

Clinical Articles, News & Views

Health and cost benefits from using a polypill

The use of a fixed-dose combination polypill to prevent recurring myocardial infarction can avoid up to 15% more fatal and non-fatal cardiovascular (CV) events, conferring potential savings to healthcare systems, according to a study published recently in the British Medical Journal.1

The study, which was conducted from a UK perspective, used a Markov model to predict the outcomes of a patient population using the polypill intervention (100 mg aspirin, 20 mg atorvastatin and 2.5, 5, or 10 mg ramipril). The patient population was selected to represent a risk profile typical of patients found in the UK and Western European countries – 72% male, mean age of 64.7 years and with a previous diagnosis of myocardial infarction. Model equations were used to determine the rates at which CV events occur as a function of baseline risks and therefore the likely effects of the person taking a polypill for a period of up to 10 years.

Cost-effectiveness assessments were made using known health economic modelling techniques to demonstrate that the 20% increase in adherence using a polypill intervention could lead to a significant reduction in deaths and non-fatal CV events – 47 per 1,000 patient population – over a 10-year period in the model examined, and a significant reduction in costs to healthcare systems.

References

1. Becerra V, Gracia A, Desai K et al. Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK. BMJ Open 2015;5. http://dx.doi.org/10.1136/bmjopen-2014-007111

Published on: June 26, 2015

Members Area

Log in or Register now.

SEARCH THE SITE

RSS FEED

Subscribe to our RSS feed
home

GET EXCLUSIVE UPDATES

Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.

RECENT COMMENTS

    None Found

ENDORSED BY

  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association
 

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.